Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study
{{output}}
Objective: HER-MES was the first head-to-head, phase 4 trial to assess the tolerability and effectiveness of erenumab against standard of care treatment (topiramate). This post hoc analysis compared the efficacy of erenumab with ... ...
